elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26829957-097B6DA3-0D53-4603-8255-B0C4ECC68732
Q26829957-097B6DA3-0D53-4603-8255-B0C4ECC68732
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26829957-097B6DA3-0D53-4603-8255-B0C4ECC68732
Novel adjunctive therapies for the treatment of tuberculosis
P2860
Q26829957-097B6DA3-0D53-4603-8255-B0C4ECC68732
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26829957-097B6DA3-0D53-4603-8255-B0C4ECC68732
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7d95b2246810fba2371b8f8ab7abb2bfad39de19
P2860
Adalimumab treatment of life-threatening tuberculosis.